Published in Cancer Weekly, June 26th, 2001
For the treatment of insulin-secreting islet cell tumors, T.A. Tirone and colleagues at Baylor College of Medicine in Houston, Texas, decided that an insulin promoter would be a logical choice for tissue-specific expression of therapeutic genes. In a current study published in the May 2001 issue of Annals of Surgery, they reported creating constructs to assess the feasibility of a rat insulin promoter for...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.